PCR Based Detection of Azole Resistance in A. Fumigatus to Improve Patient Outcome.

CompletedOBSERVATIONAL
Enrollment

320

Participants

Timeline

Start Date

April 20, 2017

Primary Completion Date

December 31, 2021

Study Completion Date

March 20, 2022

Conditions
Aspergillosis, Invasive Pulmonary
Interventions
DIAGNOSTIC_TEST

PCR based detection of azole resistance in A. fumigatus

Diagnosis and treatment of IA will be based on the results of a standardized diagnosis and treatment protocol that includes the use of the AsperGenius® PCR.

Trial Locations (8)

Unknown

Academisch Medisch Centrum, Amsterdam

VU Medisch Centrum, Amsterdam

Universitair Medisch Centrum Groningen, Groningen

Leids Universitair Medisch Centrum, Leiden

Maastricht Universitair Medisch Centrum +, Maastricht

Radboud Medisch Universitair Centrum, Nijmegen

Universitair Medisch Centrum Utrecht, Utrecht

3000 CA

Erasmus Medical Center, Rotterdam

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

lead

Erasmus Medical Center

OTHER